Bottom line
XLV vs RAGHX: the short answer
XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and RAGHX (Virtus KAR Health Sciences Fund) share a meaningful slice of their top holdings — about 49% by weight.
But XLV is far broader, holding 65 positions to 24 for RAGHX, so beyond the top names it adds exposure RAGHX doesn't have.
XLV is cheaper at 0.08% vs 1.41% — a difference of $133 a year per $10,000 invested.
Over five years, XLV returned +8.1% a year vs +2.4% for RAGHX.
RAGHX has a front-end sales load of up to 5.5%; the other does not.
Updated Nov 19, 2026
XLV vs RAGHX side by side
| XLV | RAGHX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | SPDR (State Street) | Virtus |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.08% | 1.41% |
| Annual cost per $10k | $8 | $141 |
| 10-yr cost on $10k (prospectus) | $103 | $2,148 |
| Max front load | None | 5.5% |
| 12b-1 fee | 0.02% | 0.25% |
| 1-yr return | +14.5% | +1.3% |
| 5-yr return (annualized) | +8.1% | +2.4% |
| 10-yr return (annualized) | +9.8% | +6.2% |
| Best quarter | +14.5% | — |
| Worst quarter | −12.7% | — |
| Net assets (fund) | $40.6B | $91.7M |
| Number of holdings | 65 | 24 |
| Portfolio turnover | 2% | 13% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
11 of XLV's top 25 holdings also appear in RAGHX's top 24.
| Holding | XLV | RAGHX |
|---|---|---|
| Eli Lilly & Co | 16.51% | 14.84% |
| AbbVie Inc | 7.74% | 5.52% |
| UnitedHealth Group Inc | 6.57% | 4.65% |
| Merck & Co Inc | 5.52% | 5.06% |
| Amgen Inc | 3.40% | 3.85% |
| Thermo Fisher Scientific Inc | 3.24% | 3.65% |
| Intuitive Surgical Inc | 2.45% | 3.89% |
| Vertex Pharmaceuticals Inc | 2.19% | 5.32% |
| Danaher Corp | 2.09% | 3.37% |
| McKesson Corp | 1.58% | 4.57% |
| Regeneron Pharmaceuticals Inc | 1.08% | 2.90% |
Source: SEC Form N-PORT
XLV top 10
- Eli Lilly & Co — 16.51%
- Johnson & Johnson — 10.64%
- AbbVie Inc — 7.74%
- UnitedHealth Group Inc — 6.57%
- Merck & Co Inc — 5.52%
- Amgen Inc — 3.40%
- Thermo Fisher Scientific Inc — 3.24%
- Abbott Laboratories — 2.75%
- Gilead Sciences Inc — 2.73%
- Intuitive Surgical Inc — 2.45%
RAGHX top 10
- Eli Lilly & Company — 14.84%
- West Pharmaceutical Services Inc — 5.92%
- Abbvie Inc — 5.52%
- Vertex Pharmaceuticals Inc — 5.32%
- Merck & Company Inc — 5.06%
- Unitedhealth Group Inc — 4.65%
- Mckesson Corp — 4.57%
- Mettler-toledo International Inc — 3.99%
- Intuitive Surgical Inc — 3.89%
- Amgen Inc — 3.85%
FAQ
What is the difference between XLV and RAGHX?
Which is cheaper, XLV or RAGHX?
Should I own both XLV and RAGHX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.